MENU
MTVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MetaVia (MTVA) Ownership - Who owns MetaVia?
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.35M
P/E Ratio
N/A
Total Cash
16.02M
Projected Growth
N/A
Total Debt
136K
Revenue
N/A
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash/Share
1.59
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MTVA
Capitalization
7.35M
P/E Ratio
N/A
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash
16M
Total Cash/Share
1.59
Total Debt
136K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.93M
P/B Ratio
0.94
Cash Flow
N/A
Earnings
-3.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
1.94
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-28.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-141.35
Shares Held By Institutions
2.05M
Shares Outstanding - Current
10.1M
Total Liabilities
8.33M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-64.089
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders.
Industry Biotechnology
Profile
Fundamentals
Details